Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

16 Sep 2005 13:06

ReNeuron Group plc16 September 2005 NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGINGMANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (2) An issuer making a notification in respect of a derivative relatingto the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23and 24. (3) An issuer making a notification in respect of options granted to adirector/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or RENEURON GROUP PLC (ii) DR3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial 4. State whether notification relates to a person responsibilities/director connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person JOHN SINDEN MICHAEL HUNT 5. Indicate whether the notification is in 6. Description of shares (including class), respect of a holding of the person referred debentures or derivatives or financial to in 3 or 4 above or in respect of a instruments relating to shares non-beneficial interest3 7. Name of registered shareholders(s) and, if 8. State the nature of the transaction more than one, the number of shares held by each of them 9. Number of shares, debentures or financial 10. Percentage of issued class acquired (treasury instruments relating to shares acquired shares of that class should not be taken into account when calculating percentage) 11. Number of shares, debentures or financial 12. Percentage of issued class disposed (treasury instruments relating to shares disposed shares of that class should not be taken into account when calculating percentage) 13. Price per share or value of transaction 14. Date and place of transaction 15. Total holding following notification and 16. Date issuer informed of transaction total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant 18. Period during which or date on which it can be exercised ANY TIME DURING THE PERIOD ENDING 23 JULY 2014 6 SEPTEMBER 2005 19. Total amount paid (if any) for grant of the 20. Description of shares or debentures involved option (class and number) JOHN SINDEN 650,000 ORDINARY SHARES NIL MICHAEL HUNT 900,000 ORDINARY SHARES 21. Exercise price (if fixed at time of grant) 22. Total number of shares or debentures over or indication that price is to be fixed at the time which options held following notification of exercise £0.10 PER SHARE JOHN SINDEN 1,955,260 OPTIONS AND WARRANTS MICHAEL HUNT 1,929,500 OPTIONS AND WARRANTS 23. Any additional information 24. Name of contact and telephone number for queries TIM MICKLEY, COLLINS STEWART 020 7523 8000 REPLACEMENT OPTIONS GRANTED UNDER THE COMPANY'S NEW SHARE OPTION SCHEME MICHAEL HUNT RENEURON 01483 302 560 Name and signature of duly authorised officer of issuer responsible for making notification MICHAEL HUNT CHIEF EXECUTIVE OFFICER-______________________________________ Date of notification 16/9/05 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jun 20144:40 pmRNSSecond Price Monitoring Extn
24th Jun 20144:35 pmRNSPrice Monitoring Extension
20th Jun 20143:24 pmRNSNotification of Major Interest in Shares
20th Jun 20143:18 pmRNSNotification of Major Interest in Shares
18th Jun 20147:00 amRNSPreliminary Results
3rd Jun 20147:00 amRNSNotification of Preliminary Results
14th May 201412:00 pmRNSNotification of Major Interest in Shares
8th May 20149:00 amRNSNotification of Major Interest in Shares
7th May 20147:00 amRNSFurther Data from PISCES Trial
23rd Apr 20147:00 amRNSCorporate update
15th Apr 20147:00 amRNSSigns Lease to New Facility in Wales
27th Mar 20147:00 amRNSUK Clinical Trial Approvals
17th Mar 201411:00 amRNSBlock Listing Six Monthly Review
14th Mar 201412:45 pmRNSSupport for Early Access to Medicines Scheme
21st Jan 20147:00 amRNSPublication of Positive Pre-Clinical Data
27th Dec 20134:40 pmRNSSecond Price Monitoring Extn
27th Dec 20134:35 pmRNSPrice Monitoring Extension
10th Dec 20134:40 pmRNSSecond Price Monitoring Extn
10th Dec 20134:35 pmRNSPrice Monitoring Extension
2nd Dec 20137:00 amRNSInterim Results
19th Nov 20137:00 amRNSNotification of Interim Results
17th Sep 20137:00 amRNSDirectors' Interest in Shares and Share Options
13th Sep 201311:04 amRNSResults of 2013 Annual General Meeting
13th Sep 20137:00 amRNSAGM Trading Update
29th Aug 20137:00 amRNSOrphan Drug Designation
21st Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
21st Aug 20137:00 amRNSDirector/PDMR Shareholding
15th Aug 20137:00 amRNSPosting of Annual Report & Notice of AGM
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
7th Aug 201311:03 amRNSResult of General Meeting
1st Aug 20137:00 amRNSWins £1.5 Million Grant
22nd Jul 20137:01 amRNS£33 Million Financing Package
22nd Jul 20137:00 amRNSPreliminary Results
18th Jul 20134:40 pmRNSSecond Price Monitoring Extn
18th Jul 20134:35 pmRNSPrice Monitoring Extension
1st Jul 20137:00 amRNSNotification of Preliminary Results
1st Jul 20137:00 amRNSWelcomes House of Lords Report
5th Jun 20134:40 pmRNSSecond Price Monitoring Extn
5th Jun 20134:35 pmRNSPrice Monitoring Extension
28th May 20137:00 amRNSStroke Trial Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.